CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 99 enrolled
Drug / intervention
Pregabalin +1 moredrug
Likely dose
Pregabalin 150 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00905580
NCT00905580Phase 4Completed
CompareCT.gov

Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy

Severance Hospital·interventional·Posted May 20, 2009·Updated Jan 20, 2010

In Brief

A Phase 4 clinical trial evaluating Pregabalin and Vitamin Complex (placebo) for Pain, Postoperative. Completed, enrolled 99 participants across 1 site.

Detailed Summary

The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following robot-assisted endoscopic thyroidectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be the incidence of chronic pain and hypoesthesia in the anterior chest at 3 months after operation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 20, 2009
Enrollment StartMay 1, 2009
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.1 years ago

Interventions

Pregabalindrug

Pregabalin 150 mg orally

Vitamin Complex (placebo)drug

Vitamin Complex 150 mg orally